We are live on ! Find out more
TLC

Taiwan Liposome Company, Ltd. American Depository Shares
TLC

Delisted

TLC was delisted on the 28th of September, 2021.

6 hedge funds and large institutions have $3.57M invested in Taiwan Liposome Company, Ltd. American Depository Shares in 2019 Q4 according to their latest regulatory filings, with funds opening new positions, 0 increasing their positions, 2 reducing their positions, and 1 closing their positions.

New
Increased
Maintained
Reduced
Closed

2% more capital invested

Capital invested by funds: $3.5M → $3.57M (+$73K)

0% more funds holding in top 10

Funds holding in top 10: 11 (0)

14% less funds holding

Funds holding: 76 (-1)

100% less first-time investments, than exits

New positions opened: 0 | Existing positions closed: 1

100% less repeat investments, than reductions

Existing positions increased: 0 | Existing positions reduced: 2

Holders
6
Holders Change
-1
Holders Change %
-14.29%
% of All Funds
0.12%
Holding in Top 10
1
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
0.02%
New
Increased
Reduced
2
Closed
1
Calls
Puts
Net Calls
Net Calls Change

Top Buyers

No buyers this quarter

Top Sellers

Rank Fund Capital Flow
1
Millennium Management
Millennium Management
New York
-$50.3K
2
UBS Group
UBS Group
Switzerland
-$4.95K
3
Morgan Stanley
Morgan Stanley
New York
-$1K
Name Holding Trade Value Shares
Change
Change in
Stake
KPC
1
Karst Peak Capital
Hong Kong
$3.06M
Millennium Management
2
Millennium Management
New York
$449K -$50.3K -9,707 -10%
Creative Planning
3
Creative Planning
Kansas
$54K
UBS Group
4
UBS Group
Switzerland
$4K -$4.95K -954 -56%
AG
5
Advisor Group
Arizona
$3K
HR
6
Howe & Rusling
New York
$3K
Morgan Stanley
7
Morgan Stanley
New York
-$1K -100 Closed

TLC Hedge Fund Activity: Q4 2019 in Review

6 of the 5,076 institutional investors tracked by Wall St. Rank reported a position in Taiwan Liposome Company, Ltd. American Depository Shares (TLC) for Q4 2019, worth a combined $3.57M — up 2.1% from $3.5M a quarter earlier.

Sellers outnumbered buyers: 1 fund closed out of TLC and 0 opened new positions — a net loss of 1 holder — while 2 trimmed existing stakes and 0 added.

The largest seller was Millennium Management, cutting an estimated $50.3K.

  • 6 institutional investors held Taiwan Liposome Company, Ltd. American Depository Shares (TLC) as of Q4 2019, down from 7 in Q3 2019.
  • Funds reported $3.57M of Taiwan Liposome Company, Ltd. American Depository Shares stock for Q4 2019, up 2.1% quarter-over-quarter.
  • 0 funds opened new Taiwan Liposome Company, Ltd. American Depository Shares positions in Q4 2019 and 1 closed out, a net change of -1 holder.
  • The largest Taiwan Liposome Company, Ltd. American Depository Shares seller in Q4 2019 was Millennium Management, an estimated $50.3K sold.

Based on aggregated 13F filings for Q4 2019.